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A pulsed ultrasound technique was shown to have a 
high degree of correlation with the established xerora-
diographic method for the determination of dermal 
thickness both in normal skin and corticosteroid treated 
skin, although xeroradiography consistently gave a 
higher value than ultrasound. Using the pulsed ultra-
sound technique, an early onset of dermal thinning could 
be detected 2 days following treatment with creams 
containing 0.05% clobetasol propionate and 0.1% beta-
methasone 17-valerate. The amount of dermal thinning 
produced by the clobetasol propionate preparation was 
significantly greater than that produced by cream base, 
clobetasone butyrate 0.05% cream and hydrocortisone 
1% cream as determined by both techniques. The pulsed 
ultrasound technique is an accurate, noninvasive and 
safe method for determining dermal thickness. 
Skin thinning is a well-known side effect of potent topical 
corticosteroids. Several noninvasive methods have been devel-
oped to detect dermal thinning, including the Harpenden skin-
fold caliper [1], radiological techniques [2-5] and the ratchet 
controlled micrometer (6]. Although accurate, the radiological 
methods have the disa:dvahtage of involving the use of ionising 
irradiation. The caliper and micrometer methods are less ac-
curate and suffer from the defect that in some individuals it is 
impossible to raise a fold of skin for measurement, although 
Dykes and Marks [7] found a good correlation between the 
radiological and the caliper techniques. A new and promising 
method is that based on high frequency pulsed ultrasound using 
a specially constructed probe [8]. Aiexander and Miller [8] 
demonstrated a high degree of correlation between this method 
and the established xeroradiographic method. In most studies 
of steroid induced skin thinning, measurements of skin thick-
ness have been made several weeks after the topical applica-
tions. In fact, changes in the skin can occur very soon after 
treatment. Burton and Shuster [9] showed that skin extensibil-
ity increased as early as 2 h after a high intravenous dose of 
prednisolone. In the same study 1 patient developed striae 4 
days after the injection. To fully characterise the time course 
of the changes in dermal thickness the ultrasound technique 
appears ideal, as it 'enables multiple observations to be made. 
In this ' study we have compared the pulsed ultrasound and 
the xeroradiographic techniques in the determination of dermal 
thickness before, during and after the application of topical 
corticosteroid' preparations. 
MATERIALS AND METHODS 
In this double-blind controlled investigation 48 healthy adult vol-
unteers (31 males, 17 females, age range 20-54 yr, mean age 23.7 yr) 
were treated with 2 of 6 preparations (one for ·each forearm), the 2 
treatments being drawn from the following alternatives: 
A Cream base (Cetomacrogol-1000, liquid paraffin, white soft 
paraffin) 
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B Hydrocortisone 1.0% cream 
C Hydrocortisone 17-butyrate 0.1 % cream 
D Clobetasone butyrate 0.05% cream 
E Betamethasone 17-valerate 0.1% cream 
F Clobetasol propionate 0.05% cream 
Volunteers were assigned · treatment in accordance with a randomi-
zation code. The design of this investigation was based upon a partially 
balanced incomplete blocks design [10). There were 6 treatments, 2 
treatments per block, and 2 replications of each treatment. In order to 
satisfy the requirements of this design, the subjects were a llocated a t 
random to 1 of 6 treatment pairs, AB, BC, CD, DE, EF or AF, with the 
treatments within each pair being randomly allocated to the left and 
right forearms. Thus, each treatment pair was experienced by 8 of the 
volunteers and a total of 16 subjects received each treatment. 
The test preparation was applied to the flexor aspect of the forearm 
twice a day on a left/right basis in accordance with the labeling of the 
preparations. One centimeter extrusion of the cream was applied to an 
area measuring 10 em by 5 em and volunteers were instructed not to 
wash the area for at least 1 hr after application. The total amount of 
cream applied to each area over the 6 weeks treatment period was 
approximately 30 gm. 
The radiological technique employed has been described fully by 
Marks, Dykes, and Roberts [5]. Tangential X-rays of 120 kv are directed 
at the flattened flexor aspect of the forearm and detected on a selenium 
coated plate which when developed results in a permanent positive 
image. The dermal thickness is then measured directly using a magni-
fying glass incorporating a measuring graticule. 
The ultrasound A-scan system employed is similar to that described 
by Alexander and Miller [8]. A transducer designed to operate at 15 
mHz is driven by a very fast rise- t ime pulse from the transmitter using 
transistors operating in the avalanche mode. The receiver input stage 
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FIG I. Correlation between ultrasound and xeroradiographic mea-
surements of pretreatment skin thickness. 
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comprises a dual-gate field effect transistor and the overall range 
resolution of the system is such that interfaces separated by about 0.25 
mm can be distinguished on the oscilloscope display. The transducer is 
offset from the skin by a water path to avoid confusion between the 
transmi tter pulse and the first skin echo. However, it has not been 
proved necessary to incorporate a vacuum device in order to display 
the dermis-subcutaneous fa t interface. When the ultrasound probe is 
p laced on the treated area on the forearm the transit time (T) between 
th e water-stra tum corneum interface and the dermis-subcutaneous fat 
in terface can be read from the oscilloscope display. The dermal thick-
T 
ness (L ) is given by the formula L = 2 x V. Where V, the acoustic 
velocity, is 1518 m/sec [11). 
Dermal thickness measurements by the xeroradiographic technique 
and pulsed ul trasound method were made before and after 6 weeks of 
trea tment. In addition, dermal thickness was measured using the ultra-
sound technique a lone at days 2, 4-5, 8-9, 14-1 6, 28-30 and 42-44. Four 
weeks after cessation of treatment dermal thickness was again deter-
mined by pulsed ul trasound. 
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Ftc 2. Correlation between ultrasound and xeroradiographic mea-
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various corticosteroids and cream base. 
RESULTS 
Correlation between the Pulsed Ultrasound Technique and 
Xeroradiographic Technique 
As illus tra ted by Fig 1 and 2 there was a high degree of 
correlation (Pretreatment r = 0.89 P < 0.001; Post treatment r 
= 0.96 P < 0.001) between the pulsed ultrasound technique and 
xeroradiographic techniques. This is true for the pretreatment 
normal skin as well as for the posttreatment thinned skin. 
However, both graphs show a slope of greater than 1 indicating 
that the m easurements by xeroradiography is greater than that 
of ultrasound. 
Dermal Thinning Induced by Topical Corticosteroids and 
Cream Base 
T a ble I shows the time course of changes in dermal thickness 
during_ the 10 weeks of study. Dermal thinning (ultrasound 
measurement) in the order of 4-5% could be detected as early 
as 2 days after treatment with betamethasone 17 -valerate and 
clobetasol propionate. The ranking of the dermal thinning 
pote ntial of the tested topical creams is shown on Table II. The 
dermal thinning potential of the t ested preparations can be 
roughly divided into 4 groups and the degree of thinning deter-
mined by ultrasound is greater than that of xeroradiography. 
The dermal thinning potential determined by both methods is 
on the whole consistent, with the exception of betamethasone 
17-vale ra t e and clobetasone butyrate . Ultrasound determina -
tion places the dermal thinning potential of betamethasone 17-
valerate in the same group as hydrocortisone 17-butyrate 
whereas xeroradiographic determination places it in a less atro-
TABLE II. Ranking of the dermal thinning potential of the various 
prep amtions according to the mean percentage thinning produced 
after 6 u·eells of treatment as determined by ultrasound and 
xeroradiography 
Rank-
ing 
2 
Ultrasound 
Clobetasol 
propionate 
Hydrocortisone 
17-but )Tate 
Betamethasone 
17-va lerate 
H.vdrocortisone 
Clobeta one 
butyrate 
Base 
% 
22CC 
15-1 6"< 
13"< 
gqc 
Xeroradiography 'C 
Clobet.asol 
propionate 
Hydrocortisone 
17-butyrate 
18<;< 
13% 
Betamethasone i-B'C 
17-valerate 
Hydrocortisone 
Clobetasone 
butyrate 
Base 
TA BLE I. Time course of mean dermal thiclmess expressed as p ercentages (o/c) ± standard det•iation of th e pretreatm ent derma/thickness 
va lues measured by ultrasound and xeroradiography 
Day 72 
Treatment Day 2 Day 4- 5 Dav 8-9 Day 14- 16 Day 28- 30 Day 42-44 (4 wk after 
cessation of 
treatment) 
Clobetasol propionate 96 ± 4 90 ± 9 88 ± 8 86 ± 9 80 ± 10 78 ± 12" 94 ± 7 
(82 ± 9)' 
Betamethasone 17-valerate 95 ± 4 90 ± 6 90 ± 8 88 ± 3 86 ± 7 84 ± 9 92 ± 6 
(93 ± 8) 
Hydrocortisone 1 7-butyrate 98 ± 4 90 ± 7 91 ± 8 88 ± 8 85 ± 9 83 ± 12 91 ± 8 
(87 ± 13) 
Clobetasone bu tyrate 98 ± 5 93 ± 5 94 ± 6 92 ± 6 91 ± 7 91 ± 8 96 ± 6 
(93 ± 6) 
Hydrocortisone 99 ± 5 95 ± 7 96 ± 7 95 ± 8 90 ± 8 86 ± 9 91 ± 9 
(93 ± 7) 
Base 100 ± 2 96 ± 8 96 ± 7 97 ± 6 91 ± 8 91 ± 9 95 ± 8 
(96 + 6) 
" ultrasound. 
• xeroradiography. 
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TABLE III. P-ualues obtained by an analysis of variance comparing the dermal thinning induced by the t•arious preparations after 6 weeks 
of treatment, data derived from ultrasound and xeroradiographic measurements 
Clobetasol Betamethasone Hydrocorti ·one Clobetasone Hydrocort isone propiona te !?-va lerate 17-butyrate but~·rate 
Base 
Hydrocortisone 
Clobetasone butyrate 
Hydrocortisone 17-butyrate 
Betamethasone 
" Ultrasound. 
• xeroradiography. 
,. NS = not significant. 
<0.01" 
< 0.01 1' 
<0.05 
< 0.01 
< 0.01 
<0.05 
NS 
NS 
NS 
<0.01 
<0.05 
NS' 
NS 
NS 
NS 
NS 
NS 
NS 
phogenic group together with hydrocortisone and clobetasone 
butyrate. The dermal thinning potential of clobetasone butyr-
ate as determined by ultrasound is in the order of that produced 
by base, whereas determination by xeroradiography shows that 
it has dermal thinning potential equal to that of hydrocortisone. 
The data derived from xeroradiographic and ultrasound mea-
surements were subjected to an analysis of variance. The results 
are illustrated in Table III. The degree of dermal thinning 
produced by clobetasol propionate is significantly greater than 
base, clobetasone butyrate and hydrocortisone while the degree 
of dermal thinning produced by betamethasone 17-valerate and 
hydrocortisone 17 -butyrate is significantly greater than base as 
determined by the ultrasound technique. However, the dermal 
thinning produced by clobetasol propionate as determined by 
xeroradiography is significantly greater than base, clobetasone 
butyrate, hydrocortisone and betamethasone 17 -valerate. 
Recovery from dermal· thinning, 4 weeks after cessation of 
treatment (day 72), to 91-96% of the pretreatment values IS 
apparent in all the treatment groups (Table 1) . 
DISCUSSION 
Alexander and Miller [8) first showed a very good correlation 
between the pulsed ultrasound technique and the xeroradi-
ographic technique in determining the dermal thickness in 10 
normal adult subjects. We have confirmed the usefulness of this 
technique and its high degree of correlation with the xeroradi-
ographic technique both in normal adult skin (r = 0.89) as well 
as in corticosteroid treated skin (r "" 0.96). The pulsed ultra-
sound technique is, therefore, an accurate, noninvasive tech-
nique and has the added advantages of safety and low operating 
costs. 
It should be pointed out that dermal thickness measurements 
obtained by xeroradiography give consistently greater values 
than those obtained by ultrasound. The reason for this discrep-
ancy is uncertain. Presumably, the dermal-subcutaneous fat 
interfaces detected by ultrasound and x-rays do not correspond 
to each other because of the different methods used. Sources of 
error relating to the time base calibration in the oscilloscope 
and the xerbradiographic procedure have been checked. The 
oscilloscope error was found to be +3%. The thickness of a 
metal sheet of known dimensions was deterffiined using the 
same procedure as for the xeroradiographic dermal thickness 
measurement; the radiographic image was up to 8% less than 
the true thickness of the metal sheet. By making interval 
<0.05 NS NS 
NS NS NS 
NS NS 
NS NS 
NS 
NS 
measurements with the pulsed ultrasound we were able to 
demonstrate an early onset of dem1al thinning after 2 days of 
treatment with betamethasone 17-valerate and clobetasol pro-
pionate. The accuracy of the ultrasound technique enables this 
small early change in dermal thickness to be detected. 
The ability of ultrasound and xeroradiography to detect 
dermal thinning produced by the test preparations is on the 
whole consistent, with the exception that betamethasone 17-
valerate produces less dermal thinning when determined by 
xeroradiography than by ul trasound. 
Although an inactive cream base has been used as a control 
preparation, dermal thinning could be detected after its use by 
both techniques. Kirkby and Munro [6] demonstrated a similar 
effect on mouse ears and human subjects using white soft 
paraffin with 2% liquid paraffm. We have noted similar effects 
on dermal thickness with a variety of base vehicles in previous 
studies (unpublished observations). We believe that untreated 
skin should be included in future studies alongside "placebo" 
treated area. 
We are grateful to Dr. Colin Blakemore for designing the trial and 
performing the statistical analysis. 
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